Clinical Trial Update: Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of combining Bojungikki-tang with pembrolizumab in patients with advanced non-small cell lung cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bojungikki-tang (Bojungikki-tang)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Korea Institute of Oriental Medicine | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING